EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION

被引：19
|
作者：
GAVRAS, H
BIOLLAZ, J
WAEBER, B
BRUNNER, HR
GAVRAS, I
DAVIES, RO
机构：
[1] BOSTON CITY HOSP, THORNDIKE MEM LAB, BOSTON, MA 02118 USA
[2] CHU LAUSANNE, LAUSANNE, SWITZERLAND
[3] MERCK SHARP & DOHME, West Point, PA 19486 USA
来源：
CLINICAL AND EXPERIMENTAL HYPERTENSION | 1982年 / 4卷 / 1-2期
关键词：
D O I：
10.3109/10641968209061593
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：303 / 314
页数：12
相关论文
共 50 条
  • [1] EFFECTS OF THE ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION
    GAVRAS, H
    BIOLLAZ, J
    WAEBER, B
    BRUNNER, HR
    GAVRAS, I
    SACKEL, H
    CHAROCOPOS, F
    DAVIES, RO
    CLINICAL SCIENCE, 1981, 61 : S281 - S283
  • [2] MK-421 - A NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR FOR ESSENTIAL-HYPERTENSION
    FERGUSON, RK
    VLASSES, PH
    SWANSON, BN
    COOPER, DJ
    DAVIES, RO
    ABRAMS, WB
    AMERICAN JOURNAL OF CARDIOLOGY, 1981, 47 (02): : 470 - 470
  • [3] ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421
    GAVRAS, H
    WAEBER, B
    GAVRAS, I
    BIOLLAZ, J
    BRUNNER, HR
    DAVIES, RO
    LANCET, 1981, 2 (8246): : 543 - 547
  • [4] EFFECTS OF A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, MK-421, IN NORMAL MEN AND PATIENTS
    KONO, T
    OSEKO, F
    IKEDA, F
    NAKANO, R
    TANIGUCHI, A
    IMURA, H
    ENDO, J
    ENDOCRINOLOGIA JAPONICA, 1982, 29 (05): : 615 - 622
  • [5] HEMODYNAMIC AND ANTIHYPERTENSIVE EFFECTS OF THE NEW ORAL ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR MK-421 (ENALAPRIL)
    FOUAD, FM
    TARAZI, RC
    BRAVO, EL
    TEXTOR, SC
    HYPERTENSION, 1984, 6 (02) : 167 - 174
  • [6] PHARMACOLOGICAL PROPERTIES OF THE CONVERTING ENZYME-INHIBITOR, ENALAPRIL MALEATE (MK-421)
    SWEET, CS
    FEDERATION PROCEEDINGS, 1983, 42 (02) : 167 - 170
  • [7] ENALAPRIL (MK-421), A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - ACUTE AND CHRONIC EFFECTS IN HEART-FAILURE
    DUNKMAN, WB
    WILEN, M
    FRANCIOSA, JA
    CHEST, 1983, 84 (05) : 539 - 545
  • [8] EFFECT OF THE ANGIOTENSIN-I CONVERTING ENZYME-INHIBITOR, MK-421, ON EXPERIMENTALLY INDUCED DRINKING
    FREGLY, MJ
    FATER, DC
    GREENLEAF, JE
    APPETITE, 1982, 3 (04) : 309 - 319
  • [9] ACUTE EFFECTS OF MK421, A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, IN MAN
    KASAI, Y
    ABE, K
    YASUJIMA, M
    TAJIMA, J
    SEINO, M
    CHIBA, S
    SATO, K
    GOTO, T
    OMATA, K
    TANNO, M
    YOSHINAGA, K
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 141 (04): : 417 - 422
  • [10] MK-421 - A POTENT LONG-ACTING NEW ORAL INHIBITOR OF ANGIOTENSIN CONVERTING ENZYME (ACE)
    JACKSON, B
    CUBELA, R
    JOHNSTON, CI
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1982, 9 (05) : 561 - 562
12345